CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

Published on November 6, 2023
  • CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology
  • Learnings could be leveraged to inform vaccine design for related viruses from the Arenavirus family, giving the world a head start in rapidly responding to future outbreaks in as little as 100 days
  • First project to be initiated under CEPI and University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts